• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Anita Assmann

  • share 
  • tweet 
  • share 
  • share 

Publications

Heinemann Klaas, Assmann Anita, Long term active surveillance study for oral contraceptives (LASS): final results on cardiovascular safety. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 360. DOI 10.1002.
Heinemann Klaas, Assmann Anita, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 365. DOI 10.1002.
Dinger Jürgen, Assmann Anita, Oral contraceptives and the risk of VTE: reanalysis of the EURAS/LASS study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 74.
Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 181.
Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in obese women. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 15.
Dinger Jürgen, Assmann Anita, Long-term active surveillance study for oral contraceptives (LASS): Impact of oral contraceptive use on the start of antihypertensive treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S232.
Dinger Jürgen, Assmann Anita, Moehner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.
Dinger Jürgen, Assmann Anita, Bardenheuer Kristina, Safety long-term active surveillance study for oral contraceptives (LASS): Results on venous and arterial thromboembolism. Eur J Conctracept Reprod Health Care. 2010; S1:128.
Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: Interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2010; 19:S31-32.
Dinger Jürgen, Barnett Clare, Moehner Sabine, Assmann Anita, Unintended pregnancies in women using intrauterine devices: Results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2010; 19:S242.
Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Heinemann Klaas, Leddin Janko, Drug utilization study on the prescribing indications of oral contraceptives in croatia. Pharmacoepidemiology and Drug Safety. 2010; 19:S55.
Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, Safety and effectiveness of oral contraceptives in adolescents. Eur J Contracept Reprod Health Care. 2010; 15;S1:81.
Bardenheuer Kristina, Dinger Jürgen, Assmann Anita, Leddin Janko, Unterschiede in der europäischen und US-amerikanischen Studienpopulation am Beispiel INAS-OC. Gesundheitswesen. 2010; 72:624.
Heinemann Lothar A , Dinger Jürgen, Assmann Anita, Do Minh Thai, Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare" Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014.
Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, International active surveillance study of women taking oral contraceptives (INAS-OC Study) BMC Medical Research Methodology. 2009; 9: 77.. 10.1186/1471-2288-9-77.
Dinger Jürgen, Assmann Anita, Altmann Matthias, Contraceptive efficacy of oral contraceptives under real life conditions; the impact of a 24-day regimen on contraceptive effectiveness. Pharmacoepidemiol Drug Saf. 2008; 17: S104.
Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.
Dinger Jürgen, Assmann Anita, Kuehl-Habich D, Oral contraceptives and the risk of arrhythmia: final results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2008; 17: S260.
Dinger Jürgen, Assmann Anita, Kolbeck A, Cardiovascular safety of oral hormone replacement: interim results from the EURAS-HRT study. Pharmacoepidemiol Drug Saf. 2008; 17: S270.
Dinger Jürgen, Assmann Anita, The safety of HRT under real life conditions: interim results from the EURAS HRT study. Gynecol Endocrinol. 2008; 24: S51.
van der Woude Fokke J , Heinemann Lothar A , Graf H, Lewis Michael, Moehner Sabine, Assmann Anita, Kuehl-Habich D, Analgesics use and ESRD in younger age: a case-control study BMC Nephrology. 2007; 8:15.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The safety and efficacy of oral contraceptives in teenagers: results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2007; 16: S13.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Interim results from the international active surveillance study of women taking oral contraceptives (INAS OC). Pharmacoepidemiology and Drug Safety. 2007; 16: S211.
Dinger Jürgen, Assmann Anita, Kuehl-Habich D, The safety of oral hormone replacement therapy under real life conditions: interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2007; 16: S213.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Design issues in active surveillance studies: experience from the EURAS studies.. Pharmacoepidemiology and Drug Safety. 2007; 16: S253.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.
Heinemann Lothar A , Assmann Anita, Dinger Jürgen, The risk of venous thromboembolism (VTE) in oral contraceptives: a new lesson. Pharmacoepidemiology and Drug Safety. 2006; 15: S24.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The European active surveillance study on oral contraceptives (EURAS-OC): final results after more than 130,000 WY of observatio. Pharmacoepidemiology and Drug Safety. 2006; 15: S26.
Assmann Anita, Dinger Jürgen, Heinemann Lothar A , European active surveillance of women taking HRT (EURAS-HRT). Pharmacoepidemiology and Drug Safety. 2006; 15: S73.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , International active surveillance study of women taking oral contraceptives (INAS-OC). Pharmacoepidemiology and Drug Safety. 2006; 15: S132.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The impact of obesity on the contraceptive reliability of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S140.
Spannagl M, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8.
Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Hilpert J, Spannagl M, VTE risk assessment – a prognostic model: BATER cohort study of young women Thrombosis Journal. 2005; 2005;3:5 (18 April 2005). DOI: 10.1186/1477-9560-3-5.
Heinemann Klaas, Assmann Anita, Lewis Michael, Garbe E, Heinemann Lothar A , Teichmann A T, Trend der HRT Nutzung in Deutschland 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. 2002; 43:508-511.
Heinemann Klaas, Lewis Michael, Assmann Anita, Garbe E, Heinemann Lothar A , Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 Zentralbl Gynakol. 2002; 124(2): 128-131. DOI: 10.1055/s-2002-24241.
Heinemann Klaas, Heinemann Lothar A , Assmann Anita, Schneider HPG, Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für die Deutsche Bevölkerung Zentralbl Gynakol. 2002; 124(3): 161-163. DOI: 10.1055/s-2002-32268.
Heinemann Lothar A , Assmann Anita, European Active Surveillance Study on Hormone Replacement Therapy. EURAS-HRT study protocol. Life and Medical Science Online. 2002; 3.
Heinemann Lothar A , Lewis Michael, Assmann Anita, Thiel C, Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use Contraception. 2002; Mar;65(3):207-14.
Thiel C, Heinemann Lothar A , Assmann Anita, Gründe für eine Veränderung der HRT-Therapie aus Sicht der Frauen. Zentralblatt für Gynäkologie . 2001; 123(7):390-398. DOI: 10.1055/s-2001-17036.
Heinemann Lothar A , Thiel C, Assmann Anita, Gründe und Häufigkeit von Wechsel/Stopp der Einnahme oraler Kontrazeptiva. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. Zentralbl Gynakol. 2001; 123(10): 568-577. DOI: 10.1055/s-2001-19090.
Heinemann Lothar A , Assmann Anita, Lewis Michael, How representative can be a cohort of volunteers for the general population? The German Cohort Study on Women' Health. Life and Medical Science Online. 2001; 2.
Heinemann Lothar A , Assmann Anita, Heinemann Klaas, Use of oral contraceptives containing dienogest and risk of venous thromboembolism; an extended summary report. Life and Medical Science Online. 2001; 2.
Heinemann Lothar A , Thiel C, Assmann Anita, Zimmermann T, Hummel W, Vermeulen A, Sex differences of „climacteric symptoms“ with increasing age? A pooled analysis of cross-sectional population-based surveys Aging Male. 2001; Sep;3(3):124-31.
Schramm W, Heinemann Lothar A , Spannagl M, Dick A, Assmann Anita, Die BAyerischen Thrombo-Embolie-Risiko Kohortenstudie (BATER). Studienprotokoll, Stand der Untersuchung und erste Ergebnisse.. Dtsch Med Wschr. 2000; 125:2-6.
Heinemann Lothar A , Thorogood M, Kerle K M, Assmann Anita, Do Minh Thai, Use of psychotropic drugs and risk of cardiovascular events. Life and Medical Science Online. 2000; 1.

sidebar

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Anja Bauerfeind
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Maria Cabral
  • Anitha Pitchika
  • Mohammed Dagher

Search

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.